RecruitingNCT07215624

Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study

Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network (STOP-VTE)

Sponsor

Wake Forest University Health Sciences

Enrollment

500 participants

Start Date

Jan 15, 2026

Study Type

OBSERVATIONAL

Conditions

Malignant Female Reproductive System Neoplasm Malignant Genitourinary System Neoplasm Malignant Digestive System Neoplasm

Summary

This study evaluates the use of extended venous thromboembolism prophylaxis (ePPx) following abdominopelvic cancer surgery within the NCI Community Oncology Research Program (NCORP) network, targeting surgeons and surgical advanced practice providers (APPs).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Non-Interventional Study, Non-Interventional Study, and others for people with malignant digestive system neoplasm, malignant female reproductive system neoplasm, and other related conditions. The study is currently recruiting participants at 59 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNon-Interventional Study

Non-interventional study

OTHERNon-Interventional Study

Non-interventional study

OTHERNon-Interventional Study

Non-interventional study

Locations(59)

Mercy Hospital Fort Smith

Fort Smith, Arkansas, United States

Helen F Graham Cancer Center

Newark, Delaware, United States

Medical Oncology Hematology Consultants PA

Newark, Delaware, United States

Christiana Care Health System-Christiana Hospital

Newark, Delaware, United States

Northside Hospital

Atlanta, Georgia, United States

Augusta University Medical Center

Augusta, Georgia, United States

Northside Hospital - Gwinnett

Lawrenceville, Georgia, United States

Carle Cancer Center

Urbana, Illinois, United States

Mercy Hospital

Cedar Rapids, Iowa, United States

Oncology Associates at Mercy Medical Center

Cedar Rapids, Iowa, United States

Blank Children's Hospital

Des Moines, Iowa, United States

Iowa Methodist Medical Center

Des Moines, Iowa, United States

Mercy Medical Center - Des Moines

Des Moines, Iowa, United States

Iowa Lutheran Hospital

Des Moines, Iowa, United States

MaineHealth Maine Medical Center - Portland

Portland, Maine, United States

MaineHealth Maine Medical Center- Scarborough

Scarborough, Maine, United States

Christiana Care - Union Hospital

Elkton, Maryland, United States

Trinity Health Saint Joseph Mercy Hospital Ann Arbor

Ann Arbor, Michigan, United States

Chelsea Hospital

Chelsea, Michigan, United States

Trinity Health Saint Mary Mercy Livonia Hospital

Livonia, Michigan, United States

Trinity Health Saint Joseph Mercy Oakland Hospital

Pontiac, Michigan, United States

Sanford Joe Lueken Cancer Center

Bemidji, Minnesota, United States

Essentia Health Saint Joseph's Medical Center

Brainerd, Minnesota, United States

Minnesota Oncology - Burnsville

Burnsville, Minnesota, United States

Mercy Hospital

Coon Rapids, Minnesota, United States

Essentia Health Saint Mary's Medical Center

Duluth, Minnesota, United States

Fairview Southdale Hospital

Edina, Minnesota, United States

Fairview Clinics and Surgery Center Maple Grove

Maple Grove, Minnesota, United States

Minnesota Oncology Hematology PA-Maplewood

Maplewood, Minnesota, United States

Abbott-Northwestern Hospital

Minneapolis, Minnesota, United States

Hennepin County Medical Center

Minneapolis, Minnesota, United States

Health Partners Inc

Minneapolis, Minnesota, United States

New Ulm Medical Center

New Ulm, Minnesota, United States

Park Nicollet Clinic - Saint Louis Park

Saint Louis Park, Minnesota, United States

Regions Hospital

Saint Paul, Minnesota, United States

United Hospital

Saint Paul, Minnesota, United States

Lakeview Hospital

Stillwater, Minnesota, United States

Minnesota Oncology Hematology PA-Woodbury

Woodbury, Minnesota, United States

Cox Cancer Center Branson

Branson, Missouri, United States

Mercy Hospital Joplin

Joplin, Missouri, United States

University of Kansas Cancer Center - Briarcliff

Kansas City, Missouri, United States

Liberty Hospital

Liberty, Missouri, United States

Lake Regional Hospital

Osage Beach, Missouri, United States

Mercy Hospital Springfield

Springfield, Missouri, United States

CoxHealth South Hospital

Springfield, Missouri, United States

Mercy Hospital South

St Louis, Missouri, United States

Mercy Hospital Saint Louis

St Louis, Missouri, United States

FirstHealth of the Carolinas-Moore Regional Hospital

Pinehurst, North Carolina, United States

Wake Forest NCORP Research Base

Winston-Salem, North Carolina, United States

Good Samaritan Hospital - Cincinnati

Cincinnati, Ohio, United States

Dayton Veterans Affairs Medical Center

Dayton, Ohio, United States

Mercy Hospital Oklahoma City

Oklahoma City, Oklahoma, United States

Charleston Oncology North Charleston

Charleston, South Carolina, United States

Prisma Health Greenville Memorial Hospital

Greenville, South Carolina, United States

Marshfield Clinic-Chippewa Center

Chippewa Falls, Wisconsin, United States

Saint Vincent Hospital Cancer Center Green Bay

Green Bay, Wisconsin, United States

Saint Vincent Hospital Cancer Center at Saint Mary's

Green Bay, Wisconsin, United States

Aspirus Regional Cancer Center

Wausau, Wisconsin, United States

San Patricio Medflix

Guaynabo, Puerto Rico

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07215624

Related Trials

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

NCT05564377483 locations

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

NCT06126276188 locations

Evaluation of Portal Vein Stenting in Patients With Portal Vein Stenosis and Gastrointestinal Cancers

NCT046296771 location

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

NCT040386191 location

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

NCT038192961 location